Login / Signup

Safety and Efficacy of Belimumab in Patients with Lupus Nephritis: Open-Label Extension of BLISS-LN Study.

Richard A FurieBrad H RovinFrédéric HoussiauGabriel ContrerasY K Onno TengPaula CurtisYulia GreenMohamed OkilyAnuradha MadanDavid A Roth
Published in: Clinical journal of the American Society of Nephrology : CJASN (2022)
BLISS-LN, NCT01639339.
Keyphrases
  • open label
  • systemic lupus erythematosus
  • clinical trial
  • phase ii
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • phase iii
  • locally advanced